Jean-Bernard Fourtillan

This inventor holds 7 USPTO granted patents and 1 EPO patent. Top assignees: Cemaf, Cemaf and Laboratoires Besins Iscovesco S.a., Cemaf and Laboratories Besins Isovesco S.a.. Active years: 1998-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jean-Bernard Fourtillan. Retrieved from https://idiyas.com/inventor/jean-bernard-fourtillan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7

% Patents Active = 71.4

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 4.7

ph-index = 2

Forward Citations = 45(Granted Patents)

Location History:

Migne-Auxances, FR (1998 - 2000)
Bordeaux, FR (2007)
Poitiers, FR (2002 - 2020)

Company Filing History:

Cemaf and Laboratoires Besins Iscovesco S.a.

patent

1 out of 1

Cemaf and Laboratories Besins Isovesco S.a.

patent

4. 1 out of 2

Laboratories Besins Iscovesco

patents

5. 1 out of 1

Laboratories Besins-Iscovesco S.a.

7. 2 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 1998-2020

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10744122 - Transdermal therapeutic system containing valentonin and use thereof as a medicament (2020-08-18),

2. 7291627 - Dihydroimidazo[5.1-a]-beta-carboline derivatives, method for their preparation, and their application as a drug (2007-11-06),

3. 6335346 - Pyrrolo-(3,4-b)quinoline derivatives, method for the production and use thereof as a medicament (2002-01-01),

4. 6140372 - Acyl derivatives of melatonin and of melatoninergic analogues and their (2000-10-31),

5. 6066663 - Oxidation derivatives of indolylalkylamines and their use as drugs (2000-05-23),

6. 6004991 - Acylated derivatives of melationin and its analogues, useful as (1999-12-21),

7. 5763471 - Melatoninergic agonist spiro �indolepyrrolidine! derivatives, process (1998-06-09),

Title: The Innovative Contributions of Jean-Bernard Fourtillan

Introduction

Jean-Bernard Fourtillan is a notable inventor based in Migne-Auxances, France. He has made significant contributions to the field of medicine through his innovative inventions. With a total of 7 patents, Fourtillan has focused on developing therapeutic systems and compounds that have potential applications in medical treatments.

Latest Patents

Among his latest patents is the "Transdermal therapeutic system containing valentonin and use thereof as a medicament." This invention relates to an adhesive transdermal therapeutic system that utilizes an association of valentonin (VLT) and 6-methoxyharmalan (6-MH) as its active principle. Another significant patent is for "Dihydroimidazo[5.1-a]-beta-carboline derivatives, method for their preparation, and their application as a drug." This invention concerns dihydroimidazo[-a]-β-carboline compounds, which are designed for use in medicine, particularly as hypnotics.

Career Highlights

Throughout his career, Jean-Bernard Fourtillan has worked with various companies, including Cemaf. His work has been instrumental in advancing therapeutic technologies and improving patient care through innovative drug delivery systems.

Collaborations

Fourtillan has collaborated with notable individuals in his field, including Marianne Fourtillan and Jean-Claude Jacquesy. These collaborations have contributed to the development and refinement of his inventions.

Conclusion

Jean-Bernard Fourtillan's contributions to the field of medicine through his patents highlight his innovative spirit and dedication to improving healthcare. His work continues to influence the development of new therapeutic solutions.

Profile summary based on public USPTO records.